Where Will Eli Lilly Be in 10 Years?

Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). In a decade, Eli Lilly could be in the ...

Warning as third plan to reduce their weight-loss jabs this month

Over a third of people using GLP-1 weight loss medication say they plan to reduce their dosage over Christmas so they can eat ...

Shark Tank’s Anupam Mittal warns against shortcut fitness: ‘If Ozempic becomes for fat loss what Eno is for…'

Ozempic has been widely discussed internationally for its use among celebrities and its impact on weight loss; however, the ...
Capital FM

Health advocates urge Africa to adopt WHO GLP-1 obesity guidelines

NAIROBI, Kenya, Dec 16 - Health advocates are calling on African governments to leverage new World Health Organisation (WHO) guidelines on the use of Kenya breaking news | Kenya news today | ...

Popular weight-loss drugs like Wegovy fail to lower obesity-related cancer risks, study finds

Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...

Brooks Nader on What Came After Sharing Her ‘Vulnerable’ Addiction Story

Earlier this year, Brooks Nader opened up about her addiction to weight loss drugs like Ozempic and their side effects in her ...
Body Network on MSN

I'm a Weight Loss NP and Here Are 4 Things I Warn Every Patient Before Starting GLP-1

A weight loss NP shares 4 key warnings about side effects, eating habits, and mindset to know before starting GLP-1 meds.